Advances in the understanding of the pathogenesis and epidemiology of herpes zoster

被引:211
作者
Gershon, Anne A. [2 ]
Gershon, Michael D. [3 ]
Breuer, Judith [4 ]
Levin, Myron J. [5 ]
Oaklander, Anne Louise [6 ]
Griffiths, Paul D. [1 ]
机构
[1] Univ Coll Med Sch, Ctr Virol, London NW3 2PF, England
[2] Columbia Univ Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA
[3] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA
[4] Ctr Infect Dis, London E1 2AT, England
[5] Univ Colorado Denver, Aurora, CO 80045 USA
[6] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Nerve Injury Unit, Boston, MA 02214 USA
基金
英国医学研究理事会;
关键词
Zoster; VZV; Epidemiology; Pathogenesis; VARICELLA-ZOSTER; POSTHERPETIC NEURALGIA; VIRUS-INFECTIONS; RISK-FACTORS; PHYLOGENETIC ANALYSIS; IMMUNE EVASION; UNITED-KINGDOM; VACCINE; GENOTYPES; RECOMBINATION;
D O I
10.1016/S1386-6532(10)70002-0
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The primary varicella zoster virus (VZV) infection results in chickenpox (varicella), which is transmitted via the airborne route. VZV is highly infectious, but in the USA the incidence of varicella has been reduced by 76-87% as a result of the varicella vaccine. The virus establishes latency in the dorsal root ganglia during varicella and, when reactivated, travels along the sensory nerve axons to cause shingles (herpes zoster [HZ]). There are over 1 million cases of HZ in the USA each year, with an estimated lifetime attack rate of 30%. The incidence of HZ, which causes significant morbidity, increases with age and reaches approximately 10 cases per 1,000 patient-years by age 80. Cell-mediated immunity (CMI) is known to decline with age as part of immunosenescence, and decreased CMI is associated with reactivation of VZV. This article provides an overview of our emerging understanding of the epidemiology and pathogenesis of varicella and HZ, in addition to exploring the current theories on latency and reactivation. Understanding the risk factors for developing HZ and the complications associated with infection, particularly in older people, is important for prompt diagnosis and management of HZ in primary care, and they are therefore also reviewed. (c) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:S2 / S7
页数:6
相关论文
共 52 条
  • [1] Varicella-zoster virus immune evasion
    Abendroth, A
    Arvin, A
    [J]. IMMUNOLOGICAL REVIEWS, 1999, 168 : 143 - 156
  • [2] Abendroth A, 2001, ARCH VIR S, V17, P99
  • [3] Varicella-zoster virus: Aspects of pathogenesis and host response to natural infection and varicella vaccine
    Arvin, AM
    Moffat, JF
    Redman, R
    [J]. ADVANCES IN VIRUS RESEARCH, VOL 46, 1996, 46 : 263 - 309
  • [4] CELLULAR AND HUMORAL IMMUNITY IN THE PATHOGENESIS OF RECURRENT HERPES VIRAL-INFECTIONS IN PATIENTS WITH LYMPHOMA
    ARVIN, AM
    POLLARD, RB
    RASMUSSEN, LE
    MERIGAN, TC
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1980, 65 (04) : 869 - 878
  • [5] Epidemiology of varicella zoster virus infection in Canada and the United Kingdom
    Brisson, M
    Edmunds, WJ
    Law, B
    Gay, NJ
    Walld, R
    Brownell, M
    Roos, L
    De Serres, G
    [J]. EPIDEMIOLOGY AND INFECTION, 2001, 127 (02) : 305 - 314
  • [6] IMMUNE-RESPONSES TO VARICELLA-ZOSTER IN THE AGED
    BURKE, BL
    STEELE, RW
    BEARD, OW
    WOOD, JS
    CAIN, TD
    MARMER, DJ
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1982, 142 (02) : 291 - 293
  • [7] Chen J, 2003, 28 ANN HERP WORKSH J
  • [8] THE INCIDENCE OF HERPES-ZOSTER
    DONAHUE, JG
    CHOO, PW
    MANSON, JE
    PLATT, R
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (15) : 1605 - 1609
  • [9] The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales
    Edmunds, WJ
    Brisson, M
    Rose, JD
    [J]. VACCINE, 2001, 19 (23-24) : 3076 - 3090
  • [10] Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom
    Gauthier, A.
    Breuer, J.
    Carrington, D.
    Martin, M.
    Remy, V.
    [J]. EPIDEMIOLOGY AND INFECTION, 2009, 137 (01) : 38 - 47